|
TMEM30A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.56499996190252E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.7245999617852E-09 |
| Normal-vs-Stage2 |
1.553000E-04 |
| Normal-vs-Stage3 |
6.060900E-03 |
| Normal-vs-Stage4 |
3.96690000000754E-05 |
| Stage1-vs-Stage2 |
6.462400E-01 |
| Stage1-vs-Stage3 |
2.819800E-01 |
| Stage1-vs-Stage4 |
8.533600E-01 |
| Stage2-vs-Stage3 |
6.364000E-01 |
| Stage2-vs-Stage4 |
5.148600E-01 |
| Stage3-vs-Stage4 |
3.645400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.87069956484265E-10 |
| Normal-vs-AfricanAmerican |
1.104350E-03 |
| Normal-vs-Asian |
2.200400E-03 |
| Caucasian-vs-AfricanAmerican |
1.536190E-01 |
| Caucasian-vs-Asian |
9.830400E-01 |
| AfricanAmerican-vs-Asian |
6.421600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.99790192670457E-11 |
| Normal-vs-Female |
3.750500E-02 |
| Male-vs-Female |
1.022610E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.58130000000357E-05 |
| Normal-vs-Extreme_Weight |
4.53148629731004E-12 |
| Normal-vs-Obese |
2.964900E-03 |
| Normal-vs-Extreme_Obese |
5.73870000000198E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.139400E-01 |
| Normal_Weight-vs-Obese |
2.213800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.047200E-01 |
| Extreme_Weight-vs-Obese |
3.502400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.004400E-01 |
| Obese-vs-Extreme_Obese |
2.700600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.537820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.68799999999969E-06 |
| Normal-vs-Age(61-80Yrs) |
4.84369988562605E-10 |
| Normal-vs-Age(81-100Yrs) |
1.12020000053725E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.058000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.288830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.345600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.099900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.947890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66299982065732E-10 |
| Normal-VS-Type2 PRCC |
3.42050000545768E-08 |
| Normal-VS-KIRP CIMP |
6.772200E-01 |
| Normal-VS-Unclassified PRCC |
6.656200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.033600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.954700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.673200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.321500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.434400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.506400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.79520001483991E-09 |
| Normal-vs-N1 |
1.420200E-01 |
| Normal-vs-N2 |
2.101500E-03 |
| N0-vs-N1 |
2.009900E-02 |
| N0-vs-N2 |
9.295000E-01 |
| N1-vs-N2 |
3.181000E-01 |
|
|
